Bekker, P.
1115  Ergebnisse:
Personensuche X
?
1

POS-444 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBI..:

Jayne, D. ; Merkel, P.A. ; Bekker, P....
Kidney International Reports.  7 (2022)  2 - p. S197 , 2022
 
?
2

POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBI..:

Bomback, A. ; Herlitz, L.C. ; Yue, H....
Kidney International Reports.  7 (2022)  2 - p. S47-S48 , 2022
 
?
3

POS-375 AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: EVIDENCE FO..:

Jayne, D. ; Bekker, P. ; Campbell, J..
Kidney International Reports.  6 (2021)  4 - p. S162-S163 , 2021
 
?
4

GLOMERULONEPHRITIDES:

Jayne, D. R. W. ; Bruchfeld, A. ; Schaier, M....
Nephrology Dialysis Transplantation.  29 (2014)  suppl 3 - p. iii27-iii29 , 2014
 
?
5

Diabetes - clinical:

Guebre-Egziabher, F. ; Alves, T. C. ; Perry, R. J....
Nephrology Dialysis Transplantation.  28 (2013)  suppl 1 - p. i16-i18 , 2013
 
?
8

Clinical studies in CKD 1-5:

Szotowska, M. ; Chudek, J. ; Wiecek, A....
Nephrology Dialysis Transplantation.  27 (2012)  suppl 2 - p. ii400-ii404 , 2012
 
?
 
?
 
?
 
?
 
?
13

Protect-1, a prospective randomized oral therapy evaluation..:

Bekker, P ; Petryka, R ; Vanasek, T...
Inflammatory Bowel Diseases.  14 (2008)  - p. S11 , 2008
 
?
14

To the Mirror Image:

Bekker, P.
The Opera Quarterly.  23 (2008)  2-3 - p. 311-317 , 2008
 
?
15

Traficet-EN (CCX282-B), an orally active inhibitor of chemo..:

Bekker, P ; te Velde, A ; Pronk, L...
Inflammatory Bowel Diseases.  13 (2007)  - p. 647 , 2007
 
1-15